دورية أكاديمية
Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors
| العنوان: | Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors |
|---|---|
| المؤلفون: | Lewis, K.D., Peris, K., Sekulic, A., Stratigos, A.J., Dunn, L., Eroglu, Z., Chang, A.L.S., Migden, M.R., Yoo, S.-Y., Mohan, K., Coates, E., Okoye, E., Bowler, T., Baurain, J.-F., Bechter, O., Hauschild, A., Butler, M.O., Hernandez-Aya, L., Licitra, L., Neves, R.I., Ruiz, E.S., Seebach, F., Lowy, I., Goncalves, P., Fury, M.G. |
| المساهمون: | Regeneron Pharmaceuticals, Sanofi |
| المصدر: | Annals of Oncology ; volume 35, issue 2, page 221-228 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2024 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2023.10.123 |
| الإتاحة: | https://doi.org/10.1016/j.annonc.2023.10.123Test https://api.elsevier.com/content/article/PII:S0923753423043296?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0923753423043296?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/ |
| رقم الانضمام: | edsbas.529DE8BA |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2023.10.123 |
|---|